HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Acute Myeloid Leukemia (AML) is a swiftly progressing form of cancer that impacts the blood and bone marrow. Originating in the myeloid cells responsible for producing red blood cells, platelets, and certain white blood cells, AML is marked by the rapid proliferation of abnormal cells that displace healthy blood cells. Symptoms may encompass fatigue, easy bruising or bleeding, frequent infections, and pale skin. Diagnosis typically involves blood tests and bone marrow examination.
AML treatment options span chemotherapy, stem cell transplantation, and targeted therapies, with the choice contingent on factors such as the patient's age, overall health, and specific characteristics of the leukemia cells. Early detection and prompt treatment are pivotal for improved outcomes in AML.
Ongoing research and medical advancements continually refine our comprehension of this intricate disease, paving the way for more effective treatment strategies. Regular medical check-ups and heightened awareness of potential symptoms are instrumental in managing AML
